Sign in
Not yet taking people in United StatesNo phase

Tests an elemental diet as added treatment for inflammatory bowel disease flares

Tests a liquid elemental diet alongside usual care in adults with inflammatory bowel disease flares.

Key facts

Who runs it
Wake Forest University Health Sciences
Where
Winston-Salem, United StatesSee the site
Trial code
Registry title
The EDICT Trial - Therapy for Inflammatory Bowel Disease Flares
Status
Not yet recruiting
People taking part
42 people, planned
Starts
Dec 2026
Expected to end
Jul 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • elemental diet (ED)
Record updated
28 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with ulcerative colitis or Crohn's disease who are being treated as outpatients for a flare of their disease.

Age
21 years or older
Sex
All sexes can join.
Disease stage
A flare of ulcerative colitis or Crohn's disease: a clear increase in symptoms such as belly pain, diarrhea, bleeding or fever. The person is treated as an outpatient.

Main reasons for not taking part

  • Needs to be admitted to hospital for the flare
  • Allergy to any ingredient in the mBIOTA Elemental Diet
  • Pregnant
  • Diabetes treated with insulin
  • Other medical conditions or personal preferences that would make it hard to follow the elemental diet

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • adults with an established diagnosis of inflammatory bowel disease (ulcerative colitis or Crohn's disease) who are being treated in the outpatient setting for an Inflammatory bowel disease (IBD) flare, defined as a clinically significant increase in IBD symptoms (e.g., abdominal pain, nausea, vomiting, diarrhea, joint pain, fever, bleeding, unintended weight loss)

Who cannot take part

  • Patients with allergies to any ingredients in the mBIOTA Elemental Diet
  • Patients with diabetes who are taking insulin as part of their treatment plan
  • Patients with other medical conditions or personal preferences that would compromise their ability to adhere to the elemental study
  • Patients requiring admission to the hospital for treatment of a flare
  • Female patients who are pregnant

Where in United States

  • Wake Forest University Health SciencesWinston-Salem, United StatesContact: Bradley Joseph, MDNot yet recruiting

About the trial

What the trial wants to find out

Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic inflammatory conditions of the gastrointestinal tract that affect millions of people in the United States of America. Among patients with IBD, symptomatic flares are quite common; up to 40-50% of patients in some populations report having a flare at least once per month. For most patients with IBD flares, the typical outpatient treatment consists of corticosteroids and, in some instances, initiation of or switching between 5-aminosalicylic acid-acid preparations, immunomodulators, or biologics. These treatments, while often effective, can have harmful side effects, especially when used for long durations of time. Therefore, alternative treatments are highly sought after by both patients and providers.

The 2 groups in the trial

  • elemental diet (ED)Treatment being tested

    The intervention in this study will be an elemental diet (ED) formulation produced by mBIOTA. All patients randomized to the ED arm will receive a two-week supply (84 servings + additional packets as needed) of the "original" flavor mBIOTA elemental diet.

  • control groupNo study treatment, for comparison

    Patients randomized to the control group will undergo counseling with a registered dietician for general dietary advice but will be instructed to continue their usual diet, as tolerated, without any restrictions.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Elemental Diet as an Adjunctive Therapy for Inflammatory Bowel Disease Flares The EDICT Trial
Plain-language title
Tests an elemental diet as added treatment for inflammatory bowel disease flaresGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
28 September 2026